• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Rare

Recent news which mentions Rare

< Previous 1 2 3 4 5 Next >
Expert Ratings for Ultragenyx Pharmaceutical
May 24, 2022
Tickers RARE
Tags BZI/AAR RARE Analyst Ratings
From Benzinga
Regeneron's Evkeeza Reduces Bad Cholesterol By 48% In Children Aged 5-11 Years
May 23, 2022
Tickers RARE REGN
Tags Briefs REGN Biotech
From Benzinga
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
May 19, 2022
Tickers ADMP ENTA EVO IBB
Tags COVID/19 Coronavirus COVID/19 Vaccine Movers
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
May 17, 2022
Tickers ABEO AGTC AKTX AMPE
Tags Market News ZEAL COVID/19 Vaccine
From Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Tickers ATNX AVRO AXDX BHVN
Tags RARE General PFE
From Benzinga
Citigroup Maintains Buy Rating for Ultragenyx Pharmaceutical: Here's What You Need To Know
May 10, 2022
Tickers RARE
Tags Market News Benzinga Analyst Ratings
From Benzinga
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
May 06, 2022
Tickers RARE
Tags Analyst Ratings Market News Benzinga
From Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers ABUS AGIO ALDX ARGX
Tags AXGN ABUS DSKYF
From Benzinga
Ultragenyx Pharmaceutical's Earnings Outlook
May 04, 2022
Tickers RARE
Tags BZI/EP Benzinga Market News
From Benzinga
These 20 highly rated stocks are expected to rise at least 70% over the next year
April 19, 2022
Tickers AGR AVLR AZEK CDK
Tags AZEK UBER UI
From MarketWatch
Michael Farmer Announces First-Ever Auction at Christie's of His Meteorites from the Collection of Michael Farmer March 23, 2022 Through April 6, 2022
March 31, 2022
Tickers MOON RARE
Tags Meteorites Extrema Entertainment Mars
From PRLog
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
March 16, 2022
Tickers RARE
Tags Analyst Ratings Market News Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
March 16, 2022
Tickers ACAD BEKE CEG CPTN
Tags EXPD MU Downgrades
From Benzinga
Where Ultragenyx Pharmaceutical Stands With Analysts
March 16, 2022
Tickers RARE
Tags Market News Benzinga Analyst Ratings
From Benzinga
Ultragenyx Pharmaceutical: Q4 Earnings Insights
February 10, 2022
Tickers RARE
Tags RARE BZI/Recaps Earnings
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers AGLE ALNY ALVR ARMP
Tags TWST AGLE Earnings
From Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Tickers ACB AFRM AHH ALNY
Tags OFC NSIT YELP
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers ABBV ACLX ALNY AMGN
Tags SGEN FRLN TEVA
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
Tickers OWLT OZON PACB PALI
Tags PRVB PRTS PAYA
From Benzinga
These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
November 29, 2021
Tickers ADPT AGL AI AMED
Tags DKNG VIACA NFE
From MarketWatch
Ultragenyx Pharmaceutical inc (RARE) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers RARE
Tags Market News RARE
From Motley Fool
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Tickers AADI AMGN AVNS CNTX
Tags LUNG TECH CTLT
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Tickers LDOS LEA LGIH LILA
Tags OSPN PEAK MGNX
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers ADPT AERI AGIO ALGS
Tags IPOs BNGO MRK
From Benzinga
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
September 30, 2021
Tickers RARE
Tags RARE BZI/AAR Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
September 30, 2021
Tickers AANNF ABCB ABG ACCD
Tags ACCD KRTX Initiation
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
September 27, 2021
Tickers RARE
Tags Trading Ideas Briefs Phase 2 Trial
From Benzinga
Why Shares of Solid Biosciences Are Jumping Today
September 21, 2021
Tickers BNTX MRNA PFE RARE
Tags SRPT BNTX SLDB
From Motley Fool
30 stocks that shined in the pandemic are still poised for huge growth through 2024
August 31, 2021
Tickers CHPT CRWD CVNA DKNG
Tags ZM FND OKTA
From MarketWatch
Return on Capital Employed Insights for Ultragenyx Pharmaceutical
August 19, 2021
Tickers RARE
Tags Benzinga Market News Earnings
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap